Unlock instant, AI-driven research and patent intelligence for your innovation.
6-hydrazone-8-azapurine compound and its preparation method and application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of heteropurines and compounds, applied in the field of 6-hydrazone-8-azapurine compounds and their preparation, can solve problems such as dyspnea and limit the wide-scale use of ticagrelor
Active Publication Date: 2019-04-19
BEIJING UNIV OF TECH
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Ticagrelor is the first marketed anti-platelet aggregation drug containing 8-azapurine structure, oral activity, and direct action. However, clinical studies have found that some patients taking ticagrelor have dyspnea, transient Adverse reactions such as ventricular pause and hemorrhagic risk, especially hemorrhagic events are common adverse reactions of antithrombotic drugs, which limit the wider use of ticagrelor
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0022] (1)(1S,2R,3S,4R)-6-[[5-amino-6-chloro-2-(propylthiouracil)-4-yl]-amino]-2,2-dimethyl Preparation of tetrahydro-4H-cyclopentyl[d][1,3]dioxan-4-ol
[0023] Add 4,6-dichloro-5-amino-2-propylthiopyrimidine (16.10g, 0.068mol) to 300ml 1,4-dioxane, add 2-[[(3R,4S ,6R,6S)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-alcohol mandelate (22.03g, 0.075mol) and N,N-diisopropylethylamine (43.94g, 0.34mol), heated to 100°C for reaction, the color of the reaction system gradually changed from yellow to brown, and the reaction progress was monitored by thin-layer chromatography. After 26 hours, After the basic reaction of the system is completed, cool down to room temperature, then add 500ml of water, extract, separate the liquids, extract the water phase twice with ethyl acetate, combine the organic phases, wash once with saturated saline, and dry the organic phases with anhydrous magnesium sulfate. Then the organic solvent was distilled off under reduced pressu...
[0041] The preparation method is similar to the step (3) of Example 1. Yellow solid, melting point 231.9-232.8°C. 1 H NMR (400MHz, DMSO-d 6 ): δ (ppm) 1.01 (3H, t, J = 7.3Hz), 1.72 (2H, m), 1.98 (1H, ddd, J = 13.5, 9.0, 4.4Hz), 2.64 (1H, ddd, J = 13.5 ,9.0,4.4Hz),3.15(2H,m),3.81(1H,dd,J=4.7,4.0Hz),3.96(1H,ddd,J=7.0,7.0,4.4Hz),4.73(1H,ddd, J=9.0,4.7,4.0Hz), 4.99(1H,d,J=4.0Hz),5.04(1H,q,J=9.0Hz),5.11(1H,d,J=7.0Hz),5.14(1H, d, J = 4.0Hz), 6.94 (2H, m), 7.32 (1H, t, J = 7.7Hz), 7.46 (1H, d, J = 7.6Hz), 8.42, 8.69 (1H, = CH), 11.06 ,11.49(1H,NH),12.67(1H,OH). 13 C NMR (100MHz, DMSO-d 6 ): δ (ppm) 13.76, 22.83, 32.74, 36.38, 61.68, 73.65, 74.97, 77.27, 117.41, 118.60, 119.83, 122.87, 131.41, 131.87, 148.74, 151.44, 152.81, 169.37 M+H] + :calcd446.16050,found446.16021.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a 6-hydrazone radical-8-aza-purine compound and a preparing method and an application thereof and belongs to the fields of preparation of novel compounds and medicine application. The general molecular formula of the compound is shown in the description, wherein R1 is hydroxide radical, methylol group and hydroxyethoxy, R2 is hydrogen, hydroxide radical, and fluorine, R3 is methyl, ethyl, propyl and 3,3-trifluoropropyl group, and R4 is aryl group, substitutional aryl group, ceteroary, and substitutional ceteroary. A midbody is used as reaction substrate, wherein the formula of the midbody is shown in the description, the midbody and a hydrazine and aldehydes compound are subjected to a condensation reaction, and the 6-hydrazone radical-8-aza-purine compound is obtained. According to the novel 6-hydrazone radical-8-aza-purine compound, the antiplatelet aggregation activity is high, the bleeding side effect is low, and the compound can be used for preparing the antiplatelet aggregation medicine and preventing and treating the related thrombotic disease.
Description
technical field [0001] The invention belongs to the technical field of medicine, in particular to the technical field of anti-platelet aggregation drugs, in particular to a class of 6-hydrazone-8-azapurine compounds and a preparation method thereof, and to the application of such compounds in anti-platelet aggregation drugs . Background technique [0002] Cardiovascular and cerebrovascular diseases have become one of the main causes of death in the world today, and the formation of thrombus is considered to be the direct cause of death from stroke, acute coronary syndrome and other related diseases. Antiplatelet aggregation drugs are mainstream drugs for the prevention and treatment of thrombotic cardiovascular and cerebrovascular diseases. Ticagrelor is the first marketed anti-platelet aggregation drug containing 8-azapurine structure, oral activity, and direct action. However, clinical studies have found that some patients taking ticagrelor have dyspnea, transient Advers...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More